重庆医科大学病毒性肝炎研究所,重庆,400010
Published:2007,
扫 描 看 全 文
[1]陈曜,袁刚,孙航,刘杞.肝再生增强因子联合肝细胞脾内移植治疗急性肝衰的实验研究[J].重庆医科大学学报,2007(05):474-479.
Study on effect of rALR combined with rat hepatocyte intrasplenic transplantation in rat with acute hepatic failure. [J]. Journal of Chongqing Medical University (5):474-479(2007)
[1]陈曜,袁刚,孙航,刘杞.肝再生增强因子联合肝细胞脾内移植治疗急性肝衰的实验研究[J].重庆医科大学学报,2007(05):474-479. DOI: 10.13406/j.cnki.cyxb.2007.05.016.
Study on effect of rALR combined with rat hepatocyte intrasplenic transplantation in rat with acute hepatic failure. [J]. Journal of Chongqing Medical University (5):474-479(2007) DOI: 10.13406/j.cnki.cyxb.2007.05.016.
目的:探讨应用rALR与新生大鼠肝细胞脾内移植联合治疗大鼠急性肝衰竭的疗效。方法:采用D-gal诱导大鼠急性肝衰竭模型
36h后随机分为6组:(I组:造模对照组;Ⅱ组:脾脏注射生理盐水1ml
腹腔注射生理盐水1ml/d;Ⅲ组:脾脏注射rALR 1ml(50μg/(kg·d))
腹腔注射rALR 1ml(50μg/(kg·d));Ⅳ:脾脏移植2×10
7
新生大鼠肝细胞
腹腔注射生理盐水1ml/d;V组:脾脏移植2×10
7
新生大鼠肝细胞
腹腔注射rALR 1ml;Ⅵ组:脾脏移植2×10
7
新生大鼠肝细胞
腹腔注射CsA 1ml(10mg/(kg·d))。比较各组生存率。术后第1、5天、14天获取肝组织
观察病理变化。术后第1、2、5、12天采血
检测肝功能指标。结果:Ⅱ组存活时间与I组比较无差异。Ⅲ组最长存活时间为118h
肝脏病理及肝功能改变情况基本同I组和Ⅱ组。Ⅳ组有部分长期存活
2周生存率为33.3%。V组两周存活率显著高于Ⅳ组(75%对33.3%
P
<
0.02)
Ⅵ组和Ⅳ组2周存活率比较无显著性差异(P
>
0.05)。肝功能及病理情况在Ⅳ、V、Ⅵ组有明显改善
尤以V组最为显著。)结论:应用rALR联合新生大鼠肝细胞移植能有效治疗大鼠急性肝衰竭
改善D-gal诱导的肝衰竭大鼠的存活率
促进肝功能恢复及改善肝脏病理状况。
Objective:To evaluate the treatment effects of rALR combined with newborn rat hepatocyte through intrasplenic trans- plantation in rats with acute hepatic failure induced by chemical drug.Methods:Acute hepatic failure(AHF)animals were in- duced by 1.2g/kg D-gal and randomly divided into 6 groups after intoxication.Group I as model control received no further treatment
Group II received 1ml buffered saline
groupⅢ1ml rALR
group IV 2x10~7/ml hepatocytes
group V 2x10~7hepa- tocytes suspended in lml rALR(50μg/(kg·d))and group VI 2x10~7hepatocytes in 1ml cyclosporine A(10mg/(kg·d))
through intrasplenic injection
respectively.The abdominal cavities of groupⅡ-Ⅵrats were injected with above same reagents every day till rat death or two weeks.We determined the surviving of rats in each group daily.Concurrently
surviving rats from correspondingly treated groups were killed for histology 1、5 days after operation and subsequently at weekly intervals up to 3 week to obtain histologic specimens for observing liver histopathological change.Result:The model control group rats could have survived for 88 hours at most
which proved intoxication successful.GroupⅢrats’death times were similar to group I and there was no significant difference in survival between the two groups rats.GroupⅢrats could have survived for 90 hours at most
and the liver pathological state and hepatic function change were basically the same as groupⅡrats.A proportion of group IV rats had survived for 2 weeks
and the surviving for 2 weeks was 33.3%.At 2 weeks
the survival of group V rats was significantly higher than that of groups I~IV rats(75% vs 33.3%
P<0.02)
meanwhile
it showed no statistically significant in- crease compared to that of group VI rats(75% vs 43.75%
P=0.07>0.05).there was no significant difference in survival between group IV and group VI rats(P>0.05).Hepatic function and liver pathological state for groups IV
V
VI rats had improvment
especially
group V.Conclusion:It was significant that the effect of treatment of newborn rat’s hepatocyte transplantation in combination with rALR on rat with acute hepatic function failure.It could improve the survival of rats with acute hepatic failure (AHF)induced by D-gal
and ameliorate hepatic function and hepatic pathological state.
急性肝衰竭肝再生增强因子新生大鼠肝细胞移植
Acute hepatic function failure(AHF)Rat augmenter of liver regeneration(rALR)Newborn rat hepatocyte transplantation
0
Views
76
下载量
1
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621